Clinical Trial Update: Use of a Bearable Continuous Interstitial Glucose Monitoring Device (GuardianR) During Teaching Sessions to Functional Insulin Therapy Concept in Patients Suffering From Type 1 Diabetes: Evaluation at 6 and 12 Months [NA]

View source ↗

Summary

A completed clinical trial evaluating the GuardianR continuous interstitial glucose monitoring device used during teaching sessions for functional insulin thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Diabetes Complications | NA | Status: COMPLETED